ValiRx (LSE:VAL) FCF Margin % : 0.00% (As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is ValiRx FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ValiRx's Free Cash Flow for the six months ended in Jun. 2023 was £-1.41 Mil. ValiRx's Revenue for the six months ended in Jun. 2023 was £0.00 Mil. Therefore, ValiRx's FCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, ValiRx's current FCF Yield % is -59.47%.

The historical rank and industry rank for ValiRx's FCF Margin % or its related term are showing as below:

During the past 13 years, the highest FCF Margin % of ValiRx was -1761.60%. The lowest was -3722.73%. And the median was -3628.92%.

LSE:VAL's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -148.24
* Ranked among companies with meaningful FCF Margin % only.

ValiRx FCF Margin % Historical Data

The historical data trend for ValiRx's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ValiRx FCF Margin % Chart

ValiRx Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

ValiRx Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of ValiRx's FCF Margin %

For the Biotechnology subindustry, ValiRx's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ValiRx's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ValiRx's FCF Margin % distribution charts can be found below:

* The bar in red indicates where ValiRx's FCF Margin % falls into.

ValiRx FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

ValiRx's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-1.712	/	0
	=	%

ValiRx's FCF Margin for the quarter that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2023 )	/	Revenue (Q: Jun. 2023 )
	=	-1.407	/	0
	=	%

ValiRx FCF Margin % Related Terms

Thank you for viewing the detailed overview of ValiRx's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

ValiRx (LSE:VAL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ValiRx PLC (LSE:VAL) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

EAJF:Germany

Address

4 Barling Way, Eliot Park Innovation Centre, Nuneaton, GBR, CV10 7RH

Website

https://www.valirx.com

ValiRx PLC is a UK-based biopharmaceutical company. It mainly engages in developing technologies and products in oncology therapeutics and diagnostics. The area of focus for the company is the treatment of cancer and associated biomarkers, specializing in epigenomic and genetic analysis. The company develops therapeutics across fields in oncology and has a portfolio of products in the pipeline which include GeneICE for Silencing Rebellious Genes, VAL201 for prostate cancer, NAV3 for the cancer screening test, and VAL401 for lung cancer.